GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Price, Forecast & Analysis
USA - NYSE:GRDN - US40145W1018 - Common Stock
GRDN Key Statistics, Chart & Performance
The current stock price of GRDN is 29.21 USD. In the past month the price increased by 17.07%. In the past year, price increased by 39.56%.
GRDN Latest News, Press Relases and Analysis
GRDN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MGRX | MANGOCEUTICALS INC | N/A | 15.60M | ||
| SRXH | SRX HEALTH SOLUTIONS INC | N/A | 6.09M |
Related stock screener links
About GRDN
Company Profile
Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. The company is headquartered in Atlanta, Georgia and currently employs 3,400 full-time employees. The company went IPO on 2024-09-26. Through its locally based business model, it partners with long-term care facilities (LTCF0073) to deliver medications, and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its Guardian Compass platform offers insights to enhance efficiency for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers.
Company Info
GUARDIAN PHRMCY SERVICES-A
300 Galleria Parkway SE, Suite 800
Atlanta GEORGIA US
Employees: 3400
Phone: 14048100089
GUARDIAN PHRMCY SERVICES-A / GRDN FAQ
Can you describe the business of GUARDIAN PHRMCY SERVICES-A?
Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. The company is headquartered in Atlanta, Georgia and currently employs 3,400 full-time employees. The company went IPO on 2024-09-26. Through its locally based business model, it partners with long-term care facilities (LTCF0073) to deliver medications, and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its Guardian Compass platform offers insights to enhance efficiency for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers.
Can you provide the latest stock price for GUARDIAN PHRMCY SERVICES-A?
The current stock price of GRDN is 29.21 USD. The price decreased by -3.98% in the last trading session.
What is the dividend status of GUARDIAN PHRMCY SERVICES-A?
GRDN does not pay a dividend.
What is the ChartMill technical and fundamental rating of GRDN stock?
GRDN has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is GUARDIAN PHRMCY SERVICES-A (GRDN) stock traded?
GRDN stock is listed on the New York Stock Exchange, Inc. exchange.
Should I buy GRDN stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on GRDN.
What is GUARDIAN PHRMCY SERVICES-A worth?
GUARDIAN PHRMCY SERVICES-A (GRDN) has a market capitalization of 1.85B USD. This makes GRDN a Small Cap stock.
GRDN Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to GRDN. When comparing the yearly performance of all stocks, GRDN is one of the better performing stocks in the market, outperforming 88.87% of all stocks.
GRDN Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to GRDN. While GRDN seems to be doing ok healthwise, there are quite some concerns on its profitability.
GRDN Financial Highlights
Over the last trailing twelve months GRDN reported a non-GAAP Earnings per Share(EPS) of -1.52. The EPS decreased by -567.05% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.7% | ||
| ROE | -54% | ||
| Debt/Equity | 0 |
GRDN Forecast & Estimates
10 analysts have analysed GRDN and the average price target is 29.58 USD. This implies a price increase of 1.27% is expected in the next year compared to the current price of 29.21.
For the next year, analysts expect an EPS growth of 155.83% and a revenue growth 14.6% for GRDN